Regulating the regulators: Degradation is key to the activity of the miR-21 oncomiR

July 21, 2014

Scientists from the RIKEN Center for Life Science Technologies in Japan have gained new clues that suggest the existence of a regulatory network that contributes to the irregular proliferation of cells in diseases such as cancers and psoriasis.

In recent years, the function of short strands of RNA called microRNAs has become a focus of intense research. MicroRNAs are small RNAs that regulate genes by selectively silencing their target messenger RNAs. They are often produced in variants that have some changes in sequence, but the function of these variations is often not well understood. In this research, the group looked at two variants of miR-21, a microRNA "oncomiR" known to target and which is highly expressed in a number of cancers as well as other proliferative diseases such as . It is very elevated in compared to corresponding normal tissues, and contributes to cancer by inhibiting apoptosis and stimulating proliferation, angiogenesis, and metastasis.

In the research published in the Proceedings of the National Academy of Sciences (PNAS), the researchers presented evidence suggesting that a failure to degrade miR-21 contributes to its increase in diseases. They found that miR-21 is degraded in a process that involves PAPD5, an enzyme known to be a . Based on an analysis of data from The Cancer Genome Atlas (TCGA), they concluded that this process is disrupted in many cancers, adding to the irregular accumulation of miR-21 seen in those diseases.

"We were very surprised," said Michiel de Hoon, who led the study, "at how general these results were. We saw the same processing pathway in a wide variety of diseases, with the same patterns of disruption of the pathway."

He continues, "We hope that this research will contribute to a better understanding of the pathways involving microRNAs, which are becoming more clearly implicated in a variety of diseases, and eventually to a better understanding of the mechanisms behind human diseases."

Explore further: Researchers say one specific microrna promotes tumor growth and cancer spread

More information: PAPD5-mediated 3′ adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease , PNAS, www.pnas.org/cgi/doi/10.1073/pnas.1317751111

Related Stories

A gene family that suppresses prostate cancer

March 13, 2014

Cornell University researchers report they have discovered direct genetic evidence that a family of genes, called MicroRNA-34 (miR-34), are bona fide tumor suppressors.

Recommended for you

Basic research fuels advanced discovery

August 26, 2016

Clinical trials and translational medicine have certainly given people hope and rapid pathways to cures for some of mankind's most troublesome diseases, but now is not the time to overlook the power of basic research, says ...

New method creates endless supply of kidney precursor cells

August 25, 2016

Salk Institute scientists have discovered the holy grail of endless youthfulness—at least when it comes to one type of human kidney precursor cell. Previous attempts to maintain cultures of the so-called nephron progenitor ...

New avenue for understanding cause of common diseases

August 25, 2016

A ground-breaking Auckland study could lead to discoveries about many common diseases such as diabetes, cancer and dementia. The new finding could also illuminate the broader role of the enigmatic mitochondria in human development.

Strict diet combats rare progeria aging disorders

August 25, 2016

Mice with a severe aging disease live three times longer if they eat thirty percent less. Moreover, they age much healthier than mice that eat as much as they want. These are findings of a joint study being published today ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.